奥美医疗
(002950)
| 流通市值：50.14亿 | | | 总市值：73.90亿 |
| 流通股本：4.30亿 | | | 总股本：6.33亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 896,090,731.55 | 3,671,573,075.99 | 2,596,602,769 | 1,676,335,750.73 |
| 营业收入 | 896,090,731.55 | 3,671,573,075.99 | 2,596,602,769 | 1,676,335,750.73 |
| 二、营业总成本 | 774,307,960.81 | 3,139,508,558.37 | 2,188,956,656.67 | 1,422,703,633.9 |
| 营业成本 | 603,315,715.6 | 2,621,161,322.52 | 1,818,887,281.82 | 1,179,550,690.46 |
| 税金及附加 | 9,583,996.47 | 31,378,739.2 | 22,919,344.17 | 13,865,586.07 |
| 销售费用 | 37,918,908.53 | 110,011,889.47 | 78,699,980.65 | 51,164,376.66 |
| 管理费用 | 71,198,405.84 | 258,369,140.72 | 192,534,208.85 | 128,159,419.23 |
| 研发费用 | 28,289,742.76 | 104,051,319.82 | 76,595,392.83 | 58,829,055.89 |
| 财务费用 | 24,001,191.61 | 14,536,146.64 | -679,551.65 | -8,865,494.41 |
| 其中:利息费用 | 4,569,880.8 | 17,669,454.94 | 10,040,608.79 | 7,881,655.41 |
| 其中:利息收入 | 4,060,266.79 | 16,667,208.98 | 10,458,560.82 | 7,501,407.43 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -8,014,721.06 | 7,068,508.01 | 4,226,382.65 | 4,508,565.76 |
| 加:投资收益 | 4,947,812.63 | -17,103,612.44 | -4,891,127.11 | -5,470,979.88 |
| 资产处置收益 | -3,280,731.89 | 766,842.61 | 16,906.76 | 16,906.76 |
| 资产减值损失(新) | 841,592.33 | -247,343,001.1 | -14,988,058.97 | -19,558,742.31 |
| 信用减值损失(新) | 191,334.15 | -4,024,925.41 | 3,137,092.88 | 34,839.99 |
| 其他收益 | 16,238,942.16 | 48,295,526.53 | 33,452,863.14 | 18,431,505.4 |
| 四、营业利润 | 132,706,999.06 | 319,723,855.82 | 428,600,171.68 | 251,594,212.55 |
| 加:营业外收入 | 600,424.32 | 1,348,049.22 | 646,640.6 | 623,948.57 |
| 减:营业外支出 | 1,661,722.25 | 12,056,359.02 | 1,316,855.9 | 1,159,371.28 |
| 五、利润总额 | 131,645,701.13 | 309,015,546.02 | 427,929,956.38 | 251,058,789.84 |
| 减:所得税费用 | 18,359,307.52 | 51,869,478.84 | 73,043,733.06 | 47,681,747.86 |
| 六、净利润 | 113,286,393.61 | 257,146,067.18 | 354,886,223.32 | 203,377,041.98 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 113,286,393.61 | 257,146,067.18 | 354,886,223.32 | 203,377,041.98 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 108,951,039.12 | 248,884,076.74 | 348,804,421.31 | 199,835,374.92 |
| 少数股东损益 | 4,335,354.49 | 8,261,990.44 | 6,081,802.01 | 3,541,667.06 |
| 扣除非经常损益后的净利润 | 105,010,486.04 | 213,783,473.93 | 309,182,865.98 | 185,262,341.13 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.18 | 0.4 | 0.55 | 0.32 |
| (二)稀释每股收益 | 0.18 | 0.4 | 0.55 | 0.32 |
| 八、其他综合收益 | -6,489,607.78 | -2,601,690.95 | 651,981.93 | 938,093.16 |
| 归属于母公司股东的其他综合收益 | -6,489,607.78 | -2,601,690.95 | 651,981.93 | 938,093.16 |
| 九、综合收益总额 | 106,796,785.83 | 254,544,376.23 | 355,538,205.25 | 204,315,135.14 |
| 归属于母公司股东的综合收益总额 | 102,461,431.34 | 246,282,385.79 | 349,456,403.24 | 200,773,468.08 |
| 归属于少数股东的综合收益总额 | 4,335,354.49 | 8,261,990.44 | 6,081,802.01 | 3,541,667.06 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-30 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |